|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Investments, at fair value | |||||||||||
| Investment, Unaffiliated Issuer | |||||||||||
| Non-controlled Affiliated Investment | |||||||||||
| Controlled Affiliated Investment | |||||||||||
| Total investments, at fair value | |||||||||||
| Cash | |||||||||||
| Cash Equivalents | |||||||||||
| Cash and cash equivalents | |||||||||||
| Restricted cash | |||||||||||
| Receivables: | |||||||||||
| Receivable for paydowns of investments | |||||||||||
| Interest receivable | |||||||||||
| Due from affiliates (Note 4) | |||||||||||
| Prepaid expenses and other assets | |||||||||||
| Total Assets | |||||||||||
| Liabilities | |||||||||||
| Secured Loan Facility (net of deferred financing costs of $2,354 and $2,740, respectively) | |||||||||||
| Credit Facility (net of deferred financing costs of $572 and $630, respectively) | |||||||||||
| Secured borrowing | |||||||||||
| Payables: | |||||||||||
| Payable for investments purchased | |||||||||||
| Dividend distributions payable | |||||||||||
| Management fee payable, net (Note 4) | |||||||||||
| Deferred tax liability | |||||||||||
| Interest payable | |||||||||||
| Incentive fee payable | |||||||||||
| Due to affiliates (Note 4) | |||||||||||
| Accrued professional fees | |||||||||||
| Accrued organization costs | |||||||||||
| Accrued organizational and offering costs | |||||||||||
| Accrued administrative expenses | |||||||||||
| Accrued expenses | |||||||||||
| Due to affiliates (Note 4) | |||||||||||
| Affiliated | |||||||||||
| Total due to affiliates (Note 4) | |||||||||||
| Accrued other general and administrative expenses | |||||||||||
| Administration fee payable (Note 4) | |||||||||||
| Accrued other general expense | |||||||||||
| Total Liabilities | |||||||||||
| Net Assets | |||||||||||
| Class I shares, $0.001 par value; unlimited authorized; 19,029,710 and 18,631,405 shares issued and outstanding, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Total distributable earnings (accumulated deficit) | |||||||||||
| Total Net Assets | |||||||||||
| Total Liabilities and Net Assets | |||||||||||
| Net Asset Value Per Common Share |
Loading...
